undefined undefined undefined

Impact of worsening heart failure events and renal impairment on vericiguat drug use patterns in real-world care

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Medical therapy in the context of acute heart failure

Access

Like

Risk of all-cause mortality and heart failure hospitalizations in patients treated with vericiguat in real world settings

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Amyloid and acute heart failure therapy advances

Access

Like

Age- and sex-specific characteristics and real-world use patterns of patients treated with vericiguat in Germany

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Acute heart failure - pharmacotherapy 1

Access

Like

Sex and marital status modify the effect of remote patient management on mortality risk in patients hospitalized for acute systolic heart failure: Insights from the E-INH study

Event: ESC Congress 2023

Topic: Multidisciplinary Interventions

Session: Multidisciplinary heart failure care

Access

Like

LVEF-specific effects of remote patient management in patients with heart failure: a prespecified analysis of the TIM-HF2-trial

Event: Heart Failure 2023

Topic: Treatment

Session: Chronic heart failure - treatment 1

Access

Like

Gender-specific efficacy of remote patient management (RPM) in patients with heart failure: a prespecified analysis of the TIM-HF2 trial

Event: Heart Failure 2023

Topic: Treatment

Session: Chronic heart failure - treatment 1

Access

Like

What is the best time interval for health status assessments after discharge? Findings from the E-INH study

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - Epidemiology, prognosis, outcome 4

Access

Like

MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study

Event: ESC Congress 2022

Topic: Biomarkers

Session: Chronic heart failure - Prognosis and prediction of outcome

Access

Like

Impact of marital status on long-term survival in patients with heart failure: results from the extended INH study.

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Chronic Heart Failure 1

Access

Like

undefined undefined undefined

Contributor content

Impact of worsening heart failure events and renal impairment on vericiguat drug use patterns in real-world care

Risk of all-cause mortality and heart failure hospitalizations in patients treated with vericiguat in real world settings

Age- and sex-specific characteristics and real-world use patterns of patients treated with vericiguat in Germany

Sex and marital status modify the effect of remote patient management on mortality risk in patients hospitalized for acute systolic heart failure: Insights from the E-INH study

LVEF-specific effects of remote patient management in patients with heart failure: a prespecified analysis of the TIM-HF2-trial

Gender-specific efficacy of remote patient management (RPM) in patients with heart failure: a prespecified analysis of the TIM-HF2 trial

What is the best time interval for health status assessments after discharge? Findings from the E-INH study

MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study

Impact of marital status on long-term survival in patients with heart failure: results from the extended INH study.

ESC 365 is supported by